A similar Th17 bias was reported with an intranasal subunit vaccine adjuvanted with CRX-601 (a synthetic TLR-4 agonist), where vaccine-induced Th17 responses exacerbated morbidity following influenza infection (72). Here, TLR4 is linked to influenza.